NCT06475391

Brief Summary

The purpose of this study is to evaluate if acute ingestion of L-arginine will enhance anaerobic exercise performance in young, healthy, and recreationally active adults.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 14, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 26, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 26, 2024

Status Verified

June 1, 2024

Enrollment Period

3 months

First QC Date

June 20, 2024

Last Update Submit

June 25, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Grip Strength

    Grip strength measurement in kilograms of force produced on a hand held dynamometer.

    5 minutes

  • Counter movement vertical jump

    Counter movement vertical jump performance height in centimeters.

    3 minutes

  • Wingate anaerobic cycle ergometer test

    Maximum pedaling power output for 30 seconds of all-out sprinting on a cycle ergometer.

    30 seconds

Study Arms (2)

L-arginine

EXPERIMENTAL

Participants will ingest 2 grams of L-arginine before completing three anaerobic exercise tasks (grip strength, vertical jump, and Wingate cycle ergometer test).

Dietary Supplement: L-arginine

Placebo

PLACEBO COMPARATOR

Participants will ingest 2 grams of placebo (dextrose) before completing three anaerobic exercise tasks (grip strength, vertical jump, and Wingate cycle ergometer test).

Dietary Supplement: Placebo

Interventions

L-arginineDIETARY_SUPPLEMENT

2 grams iof L-arginine will be ingested before an acute testing bout of exercise tasks in 250 mL of cranberry juice.

L-arginine
PlaceboDIETARY_SUPPLEMENT

Placebo

Placebo

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Recreationally physically active individuals will be recruited for the study. In this context it means all participants perform 1-hour of exercise per day over 3-days per week at a minimum for 1-month. All participants will be between the ages of 18-39 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Applied Research Centre; Active Living Centre

Winnipeg, Manitoba, R3T 2N2, Canada

RECRUITING

MeSH Terms

Interventions

Arginine

Intervention Hierarchy (Ancestors)

Amino Acids, BasicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, DiaminoAmino Acids, Essential

Central Study Contacts

Stephen M Cornish, PhD

CONTACT

Mikal Thrones, BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2024

First Posted

June 26, 2024

Study Start

June 14, 2024

Primary Completion

September 1, 2024

Study Completion

December 31, 2024

Last Updated

June 26, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations